Literature DB >> 16505987

Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.

R Khatib1, S Saeed, M Sharma, K Riederer, M G Fakih, L B Johnson.   

Abstract

The study presented here investigated the impact of initial antibiotic choice (beta-lactams vs vancomycin) on the outcome of 342 patients with Staphylococcus aureus bacteremia (50.9% with methicillin-resistant isolates) encountered between 1 January 2002 and 30 June 2003. Initial antibiotics were inappropriate (beta-lactams) in 60 (34.5%) methicillin-resistant cases and suboptimal (vancomycin) in 62 (36.9%) methicillin-susceptible cases. Time to effective antibiotic therapy was longer in methicillin-resistant cases (25.5+/-28.6 vs 9.6+/-16.6 h; p<0.0005). All-cause in-hospital mortality was higher with inappropriate therapy (35.0 vs 20.9%; p=0.02). Initial vancomycin treatment was associated with a higher incidence of delayed clearance (>or=3 days) of methicillin-susceptible bacteremia (56.3 vs 37.0%; p=0.03). The results indicate inappropriate initial therapy is associated with higher in-hospital mortality and initial vancomycin may delay clearance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505987     DOI: 10.1007/s10096-006-0096-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.

Authors:  Sung-Han Kim; Wan-Bum Park; Ki-Deok Lee; Cheol-In Kang; Hong-Bin Kim; Myoung-don Oh; Eui-Chong Kim; Kang-Won Choe
Journal:  Clin Infect Dis       Date:  2003-08-23       Impact factor: 9.079

3.  Dissemination of community-acquired methicillin-resistant Staphylococcus aureus clones in northern Norway: sequence types 8 and 80 predominate.

Authors:  Anne-Merethe Hanssen; Aina Fossum; Jarle Mikalsen; Dag S Halvorsen; Geir Bukholm; Johanna U Ericson Sollid
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

4.  Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia.

Authors:  Vance G Fowler; Anita Justice; Catrin Moore; Daniel K Benjamin; Christopher W Woods; Steven Campbell; L Barth Reller; G Ralph Corey; Nicholas P J Day; Sharon J Peacock
Journal:  Clin Infect Dis       Date:  2005-02-04       Impact factor: 9.079

5.  Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.

Authors:  M C Roghmann
Journal:  Arch Intern Med       Date:  2000-04-10

6.  The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection.

Authors:  L Leibovici; I Shraga; M Drucker; H Konigsberger; Z Samra; S D Pitlik
Journal:  J Intern Med       Date:  1998-11       Impact factor: 8.989

7.  Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival.

Authors:  Jordi Vallés; Jordi Rello; Ana Ochagavía; José Garnacho; Miguel Angel Alcalá
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

8.  Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.

Authors:  Thomas P Lodise; Peggy S McKinnon; Linda Swiderski; Michael J Rybak
Journal:  Clin Infect Dis       Date:  2003-05-20       Impact factor: 9.079

9.  Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.

Authors:  Olivier Lesens; Cédric Methlin; Yves Hansmann; Véronique Remy; Martin Martinot; Colm Bergin; Pierre Meyer; Daniel Christmann
Journal:  Infect Control Hosp Epidemiol       Date:  2003-12       Impact factor: 3.254

10.  Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Authors:  Stijn I Blot; Koenraad H Vandewoude; Eric A Hoste; Francis A Colardyn
Journal:  Arch Intern Med       Date:  2002-10-28
View more
  44 in total

Review 1.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

2.  Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia.

Authors:  F Hanses; C Spaeth; B P Ehrenstein; H-J Linde; J Schölmerich; B Salzberger
Journal:  Infection       Date:  2010-09-29       Impact factor: 3.553

3.  A sentinel fatal paediatric case of community-associated methicillin-resistant Staphylococcus aureus in Canada.

Authors:  Jason Brophy; Yvonne Yau; Peter Cox; Kevin Katz; Ari Bitnun
Journal:  Paediatr Child Health       Date:  2007-04       Impact factor: 2.253

4.  [Infections due to multidrug-resistant pathogens : Pathogens, resistance mechanisms and established treatment options].

Authors:  D C Richter; T Brenner; A Brinkmann; B Grabein; M Hochreiter; A Heininger; D Störzinger; J Briegel; M Pletz; M A Weigand; C Lichtenstern
Journal:  Anaesthesist       Date:  2019-10       Impact factor: 1.041

Review 5.  Clinical management of Staphylococcus aureus bacteremia: a review.

Authors:  Thomas L Holland; Christopher Arnold; Vance G Fowler
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

6.  The SUCCESS model for laboratory performance and execution of rapid molecular diagnostics in patients with sepsis.

Authors:  Mhair Dekmezian; Stacy G Beal; Mary Jane Damashek; Raul Benavides; Neelam Dhiman
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-04

7.  Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance.

Authors:  Stephen Y Liang; Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

8.  Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study.

Authors:  A J Kaasch; S Rieg; J Kuetscher; H-R Brodt; T Widmann; M Herrmann; C Meyer; T Welte; P Kern; U Haars; S Reuter; I Hübner; R Strauss; B Sinha; F M Brunkhorst; M Hellmich; G Fätkenheuer; W V Kern; H Seifert
Journal:  Infection       Date:  2013-03-29       Impact factor: 3.553

9.  Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE).

Authors:  B A Cunha; F M Pherez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-01-28       Impact factor: 3.267

10.  Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study.

Authors:  Marin L Schweizer; Jon P Furuno; Anthony D Harris; J Kristie Johnson; Michelle D Shardell; Jessina C McGregor; Kerri A Thom; George Sakoulas; Eli N Perencevich
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.